Liver carcinoma
Item
histologically confirmed hcc or diagnosis of hcc according to aasld-guidelines
boolean
C2239176 (UMLS CUI [1])
Tumor macroscopic
Item
macroscopic tumor
boolean
C0027651 (UMLS CUI [1,1])
C0439806 (UMLS CUI [1,2])
Liver disease CT | Liver disease MRI | Liver disease Ultrasonography | Liver disease Bone scan | Disease Extrahepatic Absent
Item
liver-confined disease without extrahepatic disease as diagnosed by ct, mrt, ultrasound and bone scan
boolean
C0023895 (UMLS CUI [1,1])
C0040405 (UMLS CUI [1,2])
C0023895 (UMLS CUI [2,1])
C0024485 (UMLS CUI [2,2])
C0023895 (UMLS CUI [3,1])
C0041618 (UMLS CUI [3,2])
C0023895 (UMLS CUI [4,1])
C0203668 (UMLS CUI [4,2])
C0012634 (UMLS CUI [5,1])
C1517058 (UMLS CUI [5,2])
C0332197 (UMLS CUI [5,3])
Distance Tumor Intestines
Item
minimal distance of tumor edge to the intestines of 1cm
boolean
C0012751 (UMLS CUI [1,1])
C0027651 (UMLS CUI [1,2])
C0021853 (UMLS CUI [1,3])
Age
Item
age ≥ 18 years of age
boolean
C0001779 (UMLS CUI [1])
Karnofsky Performance Status
Item
karnofsky performance score ³60
boolean
C0206065 (UMLS CUI [1])
Childbearing Potential Contraceptive methods | Gender Contraceptive methods
Item
for women with childbearing potential, (and men) adequate contraception.
boolean
C3831118 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C0079399 (UMLS CUI [2,1])
C0700589 (UMLS CUI [2,2])
Comprehension Study Protocol
Item
ability of subject to understand character and individual consequences of the clinical trial
boolean
C0162340 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
Informed Consent
Item
written informed consent (must be available before enrolment in the trial)
boolean
C0021430 (UMLS CUI [1])
Study Subject Participation Status | Refusal to Participate
Item
refusal of the patients to take part in the study
boolean
C2348568 (UMLS CUI [1])
C1136454 (UMLS CUI [2])
Prior radiation therapy Hepatobiliary System
Item
previous radiotherapy of the hepatobiliary system
boolean
C0279134 (UMLS CUI [1,1])
C1711359 (UMLS CUI [1,2])
Margin Tumor Intestines
Item
margin of < 1cm between tumor edge and intestines
boolean
C0205284 (UMLS CUI [1,1])
C0027651 (UMLS CUI [1,2])
C0021853 (UMLS CUI [1,3])
Toxicity Due to Prior Therapy | Recovery Lacking
Item
patients who have not yet recovered from acute toxicities of prior therapies
boolean
C0600688 (UMLS CUI [1,1])
C0678226 (UMLS CUI [1,2])
C1514463 (UMLS CUI [1,3])
C2004454 (UMLS CUI [2,1])
C0332268 (UMLS CUI [2,2])
Carcinoma Duration Treatment required for | Interference Investigational Therapy | Exception Carcinoma in situ of uterine cervix | Exception Basal cell carcinoma | Exception Squamous cell carcinoma of skin
Item
known carcinoma < 2 years ago (excluding carcinoma in situ of the cervix, basal cell carcinoma, squamous cell carcinoma of the skin) requiring immediate treatment interfering with study therapy
boolean
C0007097 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
C0332121 (UMLS CUI [1,3])
C0521102 (UMLS CUI [2,1])
C0949266 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0851140 (UMLS CUI [3,2])
C1705847 (UMLS CUI [4,1])
C0007117 (UMLS CUI [4,2])
C1705847 (UMLS CUI [5,1])
C0553723 (UMLS CUI [5,2])
Pregnancy | Breast Feeding
Item
pregnant or lactating women
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Study Subject Participation Status | Clinical Trial Observation Period
Item
participation in another clinical study or observation period of competing trials, respectively
boolean
C2348568 (UMLS CUI [1])
C0008976 (UMLS CUI [2,1])
C0302523 (UMLS CUI [2,2])
C1948053 (UMLS CUI [2,3])